The Diagnostic Imaging mammography modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of mammography, including 2D digital mammography, digital breast tomosynthesis, and breast ultrasound.
November 12th 2024
Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Vendors whet radiologists’ appetite for CR mammography
November 26th 2006Computed radiography arrived at the RSNA meeting Sunday ready for sale into the U.S. market as a mammography application. At the head of the pack was Fujifilm Medical Systems USA, the only vendor with FDA approval to sell CR for mammography. It received the agency green light in July.
DMIST results highlight possible downsides of digital mammography in older women
November 26th 2006New analyses of data from the Digital Mammographic Imaging Screening Trial show that digital mammography is superior only for pre- and perimenopausal women with dense breasts. Screen-film mammography may actually have an edge in older women with fatty breasts, according to a study presented at the RSNA meeting on Sunday.
Konica plans for mammography rely on FDA shift
November 21st 2006There are two ways into the U.S. market for computed radiography for mammography. One path, successfully traversed by FujiFilm Medical Systems USA and now being trod by Kodak, is the FDA's premarket approval (PMA) process. But Konica Minolta is taking the road less traveled.
FDA reviewers stay red hot in September
November 9th 2006The imaging industry tallied another 34 FDA clearances in September, pushing the running count for the year to 261. Image management led all categories with 14 devices, followed by x-ray with 10, radiotherapy with four, ultrasound and CT each with two, and nuclear medicine with one. A surgical microscope accessory that is used to view intraoperative cerebral blood flow fits none of the traditional categories.
It takes a team to keep tight ship on course
November 1st 2006I routinely read and enjoy the column by Dr. Bradley Tipler. But I was shocked and disappointed by the article in the June 2006 edition, ("Command of a tight ship stays out of reach," page 64). I work on the other side of the table.
Digital mammography begins to deliver hope
November 1st 2006For years, the world of breast imaging was quite simple. Screen-film mammography and ultrasound did not leap ahead, but they did a satisfactory job for most women. In the past few years, the armamentarium has exploded, with the introduction of modalities from MRI to vacuum biopsy. The management of breast disease has changed significantly.
Updated breast screening study revives controversy
October 31st 2006The validity of population-based breast screening has once again been called into question by the world’s media. The negative headlines have, ironically, been triggered by a report that finds mammography screening saves lives. But it is the concurrent likelihood of overdiagnosis that has captured journalists’ attention.
Hologic top exec ties growth to long-term goals
October 12th 2006Six years ago, Hologic looked like a company on the brink. Once the darling of the radiology industry with booming sales of bone densitometers, Hologic had sought to diversify, but its acquisitions were dragging the company down rather than lifting it up.
Hologic plans multiple modality unveilings at RSNA meeting
October 11th 2006Buoyed by corporate acquisitions, Hologic will appear at the RSNA meeting with a 13,000-square-foot booth filled with works-in-progress for its mammography, CAD, and densitometry offerings, and enhanced by a first-time RSNA showing of an MRI system from Esaote and the Chicago debut of its newly acquired biopsy portfolio.
Siemens plans launch of prone biopsy system
September 26th 2006Siemens Medical Solutions will launch its newly acquired MammoTest breast biopsy table at the RSNA meeting. The rights to the system were acquired by Siemens this summer from now-defunct Fischer Imaging in a deal brokered by the Federal Trade Commission. By late November, the company expects that its managers in every country will be versed in the prone stereotactic biopsy unit and ready to begin selling it globally, said Erica Rouleau, national sales director for women’s health at Siemens.
iCAD hatches plan to dominate mammography CAD
September 12th 2006FujiFilm Medical Systems USA has forged a key distribution agreement with iCAD to serve as a supplier of computer-aided detection products for Fuji’s CR mammography. As important as this deal is to Fuji, it may be even more important for iCAD.
Personal contact proves key to increasing mammography compliance
August 17th 2006More mammography facilities closed in the U.S. than opened for business between 2001 and 2004, according to a report by the Government Accountability Office released Aug. 16. The report concludes that current supply is sufficient to meet the demand, but the GAO’s reason is an indictment of U.S. healthcare.
Technology changes drive new x-ray standards
August 16th 2006The National Electrical Manufacturers Association has published two new standards for manufacturers of hard-copy and soft-copy reading devices for full-field digital mammography. The FDA-sanctioned documents should help breast imaging facilities meet their obligations under the Mammography Quality Standards Act.